Indications and uses
■ Temporarily relieves the symptoms of: ■ restlessness ■ anxiousness ■ nervousness ■ irritability ■ apprehensiveness
■ Temporarily relieves the symptoms of: ■ restlessness ■ anxiousness ■ nervousness ■ irritability ■ apprehensiveness
■ Use as directed. Adults and children 12 years and over Dissolve 1-2 tablets under tongue 3 times per day. Sudden onset: every 15 minutes until relieved, up to 6 doses. Children 6 years to under 12 years Dissolve 1 tablet under tongue 3 times per day. Sudden onset: every 15 minutes until relieved, up to 6 doses.
stress relief, calms nervousness
Active ingredients | Purpose |
Calcarea Phosphorica 3X HPUS | restlessness, anxiousness |
Ferrum Phosphoricum 3X HPUS | nervousness |
Kali Phosphoricum 3X HPUS | irritability,nervousness |
Magnesia Phosphorica 3X HPUS | anxiousness |
Natrum Phosphoricum 3X HPUS | irritability,apprehensiveness |
“HPUS” indicates that the active ingredients are in the official Homeopathic Pharmacopœia of the United States.
■ Temporarily relieves the symptoms of: ■ restlessness ■ anxiousness ■ nervousness ■ irritability ■ apprehensiveness
Symptoms persist more than 7 days or worsen.
Ask a health professional before use.
■ Use as directed.
| Adults and children
12 years and over | Dissolve 1-2 tablets under tongue 3 times per day.
Sudden onset: every 15 minutes until relieved, up to 6 doses. |
| Children 6 years
to under 12 years | Dissolve 1 tablet under tongue 3 times per day.
Sudden onset: every 15 minutes until relieved, up to 6 doses. |
Acacia Gum, Lactose.
www.hylands.com or (800) 624-9659
Uses
■ Temporarily relieves the symptoms of: ■ restlessness ■ anxiousness ■ nervousness ■ irritability ■ apprehensiveness
Directions
Adults and children 12 years and over: Dissolve 1-2 tablets under tongue, up to 3 times per day. Sudden onset: every 15 minutes until relieved, up to 6 doses.
Children 6 years to under 12 years: Dissolve 1 tablet under tongue, up to 3 times per day. Sudden onset: every 15 minutes until relieved, up to 6 doses.
Hyland's
NERVE
TONIC®
STRESS RELIEF*
Nervousness
Anxiousness
Non-Habit
Forming
50
QUICK-DISSOLVING TABLETS
HOMEOPATHIC
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CALCIUM PHOSPHATE | ACTIVE INGREDIENT | 97Z1WI3NDX | 1 | |
| IRON | ACTIVE INGREDIENT | E1UOL152H7 | 1 | |
| MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE | ACTIVE INGREDIENT | HF539G9L3Q | 1 | |
| POTASSIUM PHOSPHATE, UNSPECIFIED FORM | ACTIVE INGREDIENT | B7862WZ632 | 1 | |
| SODIUM PHOSPHATE | ACTIVE INGREDIENT | SE337SVY37 | 1 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | 1 | |
| IRON | ACTIVE MOIETY | E1UOL152H7 | 1 | |
| MAGNESIUM CATION | ACTIVE MOIETY | T6V3LHY838 | 1 | |
| PHOSPHATE ION | ACTIVE MOIETY | NK08V8K8HR | 1 | |
| POTASSIUM PHOSPHATE, UNSPECIFIED FORM | ACTIVE MOIETY | B7862WZ632 | 1 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 54973-3014 | 54973-3014-2, 54973-3014-3, 54973-3014-4 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CALCIUM PHOSPHATE, UNSPECIFIED FORM | 97Z1WI3NDX | ACTIB |
| IRON | E1UOL152H7 | ACTIB |
| POTASSIUM PHOSPHATE, UNSPECIFIED FORM | B7862WZ632 | ACTIB |
| MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE | HF539G9L3Q | ACTIB |
| SODIUM PHOSPHATE | SE337SVY37 | ACTIB |
| LACTOSE, UNSPECIFIED FORM | J2B2A4N98G | IACT |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 9 | 2025-04-10 | full-release | 2026-06-01 02:33:13 |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 326e9f4c-b6e9-4798-e063-6394a90aa038 | c7ea84ee-5844-4b14-9792-2c45729fccab | 2025-04-10 | Warnings | c7ea84ee-5844-4b14-9792-2c45729fccab |
Adverse event summaries are temporarily unavailable. Other product information remains available.